• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见病患者的诊断时间和诊断延迟的决定因素:罕见病晴雨表回顾性患者调查结果。

Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey.

机构信息

EURORDIS-Rare Diseases Europe, Paris, France.

HHT Europe, Roma, Italy.

出版信息

Eur J Hum Genet. 2024 Sep;32(9):1116-1126. doi: 10.1038/s41431-024-01604-z. Epub 2024 May 16.

DOI:10.1038/s41431-024-01604-z
PMID:38755315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11369105/
Abstract

Timely diagnosis is one of the most serious challenges faced by people living with a rare disease (PLWRD), and this study estimates that in Europe, the average total diagnosis time (TDT) is close to 5 years. We investigated the duration of the TDT for PLWRD in Europe, the difficulties associated with their diagnosis odyssey and the main determinants of diagnosis delays for all rare diseases (RD). We conducted a survey of PLWRD and their families using Rare Barometer, the survey initiative of EURORDIS-Rare Diseases Europe. In geographical Europe, we surveyed 6507 people living with 1675 RD in 41 countries. We then performed a descriptive analysis and ordinal logistic regressions to identify the main determinants of diagnosis delays. Average TDT is 4.7 years. 56% of respondents were diagnosed more than 6 months after a first medical contact. The main determinants of diagnosis delays are symptom onset before 30 years of age, especially during childhood (OR = 3.11; 95% CI: 2.4-4.0) and adolescence (OR = 4.79; 95% CI: 3.7-6.2), being a woman (OR = 1.22; 95% CI:1.1-1.4), living in Northern Europe (OR = 2.15; 95% CI:1.8-2.6) or Western Europe (OR = 1.96; 95% CI:1.6-2.3), the number of healthcare professionals consulted (OR = 5.15; 95% CI:4.1-6.4), misdiagnosis (OR = 2.48; 95% CI:2.1-2.9), referral to a centre of expertise (OR = 1.17; 95% CI:1.0-1.3), unmet needs for psychological support (OR = 1.34; 95% CI:1.2-1.5) and financial support (OR = 1.16; 95% CI:1.0-1.3), having a genetic disease (OR = 1.33; 95% CI:1.1-1.5) and a family history of an RD (OR = 1.36; 95% CI:1.1-1.6). These determinants can inform policies and actions to improve access to diagnosis for all PLWRD.

摘要

及时诊断是罕见病患者(PLWRD)面临的最严峻挑战之一,本研究估计,在欧洲,罕见病的平均总诊断时间(TDT)接近 5 年。我们调查了欧洲罕见病患者的 TDT 持续时间、诊断困难以及所有罕见病(RD)诊断延迟的主要决定因素。我们使用 EURORDIS-Rare Diseases Europe 的调查计划 Rare Barometer 对 PLWRD 及其家属进行了调查。在地理上的欧洲,我们在 41 个国家调查了 6507 名患有 1675 种 RD 的患者。然后,我们进行了描述性分析和有序逻辑回归,以确定诊断延迟的主要决定因素。平均 TDT 为 4.7 年。56%的受访者在首次就诊后 6 个月以上才被诊断出疾病。诊断延迟的主要决定因素是 30 岁前发病,尤其是儿童期(OR=3.11;95%CI:2.4-4.0)和青春期(OR=4.79;95%CI:3.7-6.2),女性(OR=1.22;95%CI:1.1-1.4),居住在北欧(OR=2.15;95%CI:1.8-2.6)或西欧(OR=1.96;95%CI:1.6-2.3),就诊的医护人员数量(OR=5.15;95%CI:4.1-6.4),误诊(OR=2.48;95%CI:2.1-2.9),转诊至专科中心(OR=1.17;95%CI:1.0-1.3),心理支持需求未得到满足(OR=1.34;95%CI:1.2-1.5)和财务支持(OR=1.16;95%CI:1.0-1.3),患有遗传疾病(OR=1.33;95%CI:1.1-1.5)和家族中存在 RD(OR=1.36;95%CI:1.1-1.6)。这些决定因素可以为改善所有 PLWRD 的诊断提供政策和行动信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f800/11369105/12e91c456ce0/41431_2024_1604_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f800/11369105/685e79599ebc/41431_2024_1604_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f800/11369105/3827276998f6/41431_2024_1604_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f800/11369105/12e91c456ce0/41431_2024_1604_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f800/11369105/685e79599ebc/41431_2024_1604_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f800/11369105/3827276998f6/41431_2024_1604_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f800/11369105/12e91c456ce0/41431_2024_1604_Fig3_HTML.jpg

相似文献

1
Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey.罕见病患者的诊断时间和诊断延迟的决定因素:罕见病晴雨表回顾性患者调查结果。
Eur J Hum Genet. 2024 Sep;32(9):1116-1126. doi: 10.1038/s41431-024-01604-z. Epub 2024 May 16.
2
Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.患有罕见疾病的澳大利亚儿童:诊断经历及诊断延迟的感知后果
Orphanet J Rare Dis. 2017 Apr 11;12(1):68. doi: 10.1186/s13023-017-0622-4.
3
[Diagnostic delay of rare diseases in Europe and in Hungary].[欧洲及匈牙利罕见病的诊断延误]
Orv Hetil. 2012 Jul 29;153(30):1185-90. doi: 10.1556/OH.2012.29418.
4
The management of rare disease patients from a grassroot perspective: the role of patients' organizations in the global recognition of rare diseases in Cameroon.基层视角下的罕见病患者管理:以喀麦隆为例看患者组织在全球罕见病认可中的作用。
Pan Afr Med J. 2024 Feb 13;47:64. doi: 10.11604/pamj.2024.47.64.38226. eCollection 2024.
5
Diagnostic Process in Rare Diseases: Determinants Associated with Diagnostic Delay.罕见病诊断流程:与诊断延迟相关的决定因素。
Int J Environ Res Public Health. 2022 May 26;19(11):6456. doi: 10.3390/ijerph19116456.
6
Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry.罕见病诊断延迟:来自西班牙罕见病患者登记处的数据。
Orphanet J Rare Dis. 2022 Nov 17;17(1):418. doi: 10.1186/s13023-022-02530-3.
7
Diagnostic Delays in Children With Coeliac Disease in the Central European Region.儿童乳糜泻在中欧地区的诊断延误。
J Pediatr Gastroenterol Nutr. 2019 Oct;69(4):443-448. doi: 10.1097/MPG.0000000000002424.
8
Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey.COVID-19 大流行对罕见病患者及其家庭的影响:一项全国性调查的结果。
JMIR Public Health Surveill. 2024 Feb 14;10:e48430. doi: 10.2196/48430.
9
Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support.澳大利亚罕见病患者家庭:诊断经历、卫生服务利用情况以及对心理社会支持的需求。
Orphanet J Rare Dis. 2013 Feb 11;8:22. doi: 10.1186/1750-1172-8-22.
10
Survey of parent and carer experiences and expectations of paediatric rheumatology care in New South Wales.新南威尔士州家长及照料者对儿科风湿病护理的体验与期望调查。
Aust Health Rev. 2017 Aug;41(4):372-377. doi: 10.1071/AH16061.

引用本文的文献

1
Diagnostic Impasse and Wandering in Patients With Rare Neuromuscular Diseases: Insights Into Patient Characteristics From the French National Network for Rare Neuromuscular Diseases (FILNEMUS) and the French National Rare Disease Database (BNDMR).罕见神经肌肉疾病患者的诊断困境与徘徊:来自法国国家罕见神经肌肉疾病网络(FILNEMUS)和法国国家罕见病数据库(BNDMR)对患者特征的见解。
Eur J Neurol. 2025 Sep;32(9):e70347. doi: 10.1111/ene.70347.
2
Health care supply in patients with Ehlers-Danlos syndromes and generalized hypermobility spectrum disorder: a German perspective.埃勒斯-当洛综合征和广泛性关节过度活动谱系障碍患者的医疗保健供应:德国视角
Orphanet J Rare Dis. 2025 Aug 16;20(1):436. doi: 10.1186/s13023-025-03937-4.
3

本文引用的文献

1
Rare diseases: still on the fringes of universal health coverage in Europe.罕见病:在欧洲仍处于全民健康覆盖的边缘
Lancet Reg Health Eur. 2023 Dec 11;37:100783. doi: 10.1016/j.lanepe.2023.100783. eCollection 2024 Feb.
2
Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry.罕见病诊断延迟:来自西班牙罕见病患者登记处的数据。
Orphanet J Rare Dis. 2022 Nov 17;17(1):418. doi: 10.1186/s13023-022-02530-3.
3
The diagnostic odyssey: insights from parents of children living with an undiagnosed condition.
Anxiety and quality-of-life for parents of children with undiagnosed rare conditions: A multi-site quantitative survey study.
未确诊罕见病患儿家长的焦虑与生活质量:一项多中心定量调查研究
J Genet Couns. 2025 Aug;34(4):e70085. doi: 10.1002/jgc4.70085.
4
Female gender and quality of life outcomes in myasthenia gravis: a systematic review and meta-analysis.重症肌无力患者的女性性别与生活质量结局:一项系统评价与荟萃分析
Ther Adv Neurol Disord. 2025 Jul 14;18:17562864251344742. doi: 10.1177/17562864251344742. eCollection 2025.
5
Criteria to evaluate unmet health-related needs of persons living with rare diseases and their caregivers: rapid literature review and stakeholder consultations.评估罕见病患者及其照护者未满足的健康相关需求的标准:快速文献综述和利益相关者咨询
Orphanet J Rare Dis. 2025 Jul 1;20(1):321. doi: 10.1186/s13023-025-03838-6.
6
Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future.遗传性血管性水肿的诊断:回顾过去,展望未来。
World Allergy Organ J. 2025 May 14;18(6):101060. doi: 10.1016/j.waojou.2025.101060. eCollection 2025 Jun.
7
Artificial intelligence applications in rare and intractable diseases: Advances, challenges, and future directions.人工智能在罕见病和疑难病中的应用:进展、挑战及未来方向
Intractable Rare Dis Res. 2025 May 31;14(2):88-92. doi: 10.5582/irdr.2025.01030.
8
Cell Modeling and Rescue of a Novel Non-coding Genetic Cause of Glycogen Storage Disease IX.糖原贮积病IX型一种新型非编码遗传病因的细胞建模与挽救
bioRxiv. 2025 May 17:2025.05.14.654043. doi: 10.1101/2025.05.14.654043.
9
The impact of 22q11.2 deletion syndrome on caregivers: assessing quality of life and burden.22q11.2缺失综合征对照料者的影响:评估生活质量和负担。
Orphanet J Rare Dis. 2025 Jun 1;20(1):264. doi: 10.1186/s13023-025-03790-5.
10
Diagnosis of Inherited Metabolic Disease in Older Patients: A Systematic Literature Review.老年患者遗传性代谢疾病的诊断:一项系统文献综述。
J Inherit Metab Dis. 2025 May;48(3):e70038. doi: 10.1002/jimd.70038.
诊断之旅:患有未确诊疾病儿童的父母的见解。
Orphanet J Rare Dis. 2022 Jun 18;17(1):233. doi: 10.1186/s13023-022-02358-x.
4
Diagnostic Process in Rare Diseases: Determinants Associated with Diagnostic Delay.罕见病诊断流程:与诊断延迟相关的决定因素。
Int J Environ Res Public Health. 2022 May 26;19(11):6456. doi: 10.3390/ijerph19116456.
5
Emotional experience of the diagnostic process of a rare disease and the perception of support systems: A scoping review.罕见病诊断过程中的情绪体验及对支持系统的感知:范围综述。
J Clin Nurs. 2022 Jan;31(1-2):20-31. doi: 10.1111/jocn.15922. Epub 2021 Jun 16.
6
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.估算罕见病的累计点患病率:对孤儿药数据库的分析。
Eur J Hum Genet. 2020 Feb;28(2):165-173. doi: 10.1038/s41431-019-0508-0. Epub 2019 Sep 16.
7
'It would be much easier if we were just quiet and disappeared': Parents silenced in the experience of caring for children with rare diseases.“如果我们只是保持安静然后消失,那会容易得多”:照顾罕见病儿童的父母在体验中被噤声。
Health Expect. 2019 Dec;22(6):1251-1259. doi: 10.1111/hex.12958. Epub 2019 Aug 29.
8
The Caregiving Experiences of Fathers and Mothers of Children With Rare Diseases in Italy: Challenges and Social Support Perceptions.意大利罕见病患儿父母的照料经历:挑战与社会支持认知
Front Psychol. 2019 Aug 5;10:1780. doi: 10.3389/fpsyg.2019.01780. eCollection 2019.
9
Share and protect our health data: an evidence based approach to rare disease patients' perspectives on data sharing and data protection - quantitative survey and recommendations.分享和保护我们的健康数据:基于证据的罕见病患者对数据共享和数据保护观点 - 定量调查和建议。
Orphanet J Rare Dis. 2019 Jul 12;14(1):175. doi: 10.1186/s13023-019-1123-4.
10
Current Genetic Service Delivery Models for the Provision of Genetic Testing in Europe: A Systematic Review of the Literature.欧洲当前提供基因检测的基因服务提供模式:文献系统综述
Front Genet. 2019 Jun 19;10:552. doi: 10.3389/fgene.2019.00552. eCollection 2019.